iobitridol has been researched along with Hyperlipoproteinemia Type II in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alomar Serrallach, X; Barros Membrilla, A; Cardona Olle, M; Carreras Costa, F; Franco Peral, M; Hidalgo Perez, JA; Leta Petracca, R; Pons-Lladó, G; Pujadas Olano, S; Viladés Medel, D | 1 |
1 other study(ies) available for iobitridol and Hyperlipoproteinemia Type II
Article | Year |
---|---|
Coronary computed tomographic angiographic findings in asymptomatic patients with heterozygous familial hypercholesterolemia and null allele low-density lipoprotein receptor mutations.
Topics: Age Factors; Alleles; Case-Control Studies; Chi-Square Distribution; Comorbidity; Contrast Media; Coronary Angiography; Coronary Artery Disease; Female; Humans; Hyperlipoproteinemia Type II; Iohexol; Lipids; Logistic Models; Male; Middle Aged; Mutation; Phenotype; Prevalence; Receptors, LDL; Risk Factors; Severity of Illness Index; Statistics, Nonparametric; Tomography, X-Ray Computed | 2013 |